Nxera Pharma Co (Nxera Pharma Co) Interest Expense : $-18.3 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nxera Pharma Co's interest expense for the three months ended in Mar. 2024 was $ -1.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-18.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nxera Pharma Co's Operating Income for the three months ended in Mar. 2024 was $ -20.5 Mil. Nxera Pharma Co's Interest Expense for the three months ended in Mar. 2024 was $ -1.2 Mil. Nxera Pharma Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nxera Pharma Co Interest Expense Historical Data

The historical data trend for Nxera Pharma Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Interest Expense Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-4.52

-5.57

-33.36

-5.60

-17.33

Nxera Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.29	-1.39	-4.37	-11.32	-1.24

Nxera Pharma Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.3 Mil.

Nxera Pharma Co (OTCPK:SOLTF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nxera Pharma Co's Interest Expense for the three months ended in Mar. 2024 was $-1.2 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-20.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $439.4 Mil.

Nxera Pharma Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Nxera Pharma Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.